Get the Stockscreener App
0.00
100.00%
-3.20
OncoCyte Corporation stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
OncoCyte Corporation focuses on the development and commercialization of novel and non-invasive blood and urine (liquid biopsy) diagnostic tests for the early detection of cancer. The company is developing diagnostic tests using genetic and protein markers expressed in various types of cancer. It develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancer. The company was founded in 2009 and is based in Alameda, California. OncoCyte Corporation is a subsidiary of BioTime, Inc.
See More
Previous Close:
$3.20
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$75.50M
Revenue:
$709.00K
Net Income/Loss:
$-43.14M
P/E Ratio:
0.00
EPS:
-4.54
Net Cash Flow:
$-20.35M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$4.75
OncoCyte Corporation Stock (OCX) Company Profile
Name
OncoCyte Corporation
Sector
Industry
Phone
510-775-0515
Address
1010 Atlantic Avenue, Suite 102, Alameda, CA
Compare OCX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OCX
OncoCyte Corporation
|
0.00 | 75.50M | 709.00K | -43.14M | -20.35M | -4.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
405.30 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.00 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.12 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
772.87 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
342.30 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
OncoCyte Corporation Stock (OCX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-28-25 | Initiated | Lake Street | Buy |
| May-24-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-14-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-07-22 | Initiated | Stephens | Overweight |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Mar-17-21 | Resumed | Needham | Buy |
| Jan-07-21 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-16-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-30-20 | Initiated | BTIG Research | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-30-20 | Reiterated | The Benchmark Company | Speculative Buy |
| Jul-01-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jun-30-20 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jun-02-20 | Initiated | Needham | Buy |
| Feb-13-19 | Initiated | Piper Jaffray | Overweight |
| Jan-29-19 | Upgrade | Janney | Neutral → Buy |
| Dec-19-18 | Resumed | Lake Street | Buy |
View All
OncoCyte Corporation Stock (OCX) Latest News
Will OncoCyte Corporation stock recover after recent drop2025 Trade Ideas & Real-Time Chart Breakout Alerts - newser.com
Volume spikes in OncoCyte Corporation stock – what they meanMarket Volume Report & Capital Efficient Trading Techniques - newser.com
Can technical indicators confirm OncoCyte Corporation’s reversal2025 Market WrapUp & Safe Capital Allocation Plans - newser.com
Is OncoCyte Corporation stock attractive for growth ETFs2025 Top Decliners & AI Driven Price Predictions - newser.com
Is OncoCyte Corporation meeting your algorithmic filter criteriaMarket Activity Report & Growth Oriented Trade Recommendations - newser.com
Oncocyte gains 6% on $10.2M private placement - MSN
Ranking OncoCyte Corporation among high performing stocks via toolsJuly 2025 Catalysts & Detailed Earnings Play Strategies - newser.com
OncoCyte Corporation stock trendline breakdown2025 EndofYear Setup & High Accuracy Trade Alerts - newser.com
What drives OncoCyte Corporation stock priceMarket Profile Overview & Investment Timing Techniques - Early Times
Is OncoCyte Corporation a good long term investmentVolume Profile Analysis & Learn the Secrets of Pro Traders - Early Times
Is OncoCyte Corporation stock attractive for ETFsDollar Strength & AI Enhanced Trading Alerts - newser.com
Using RSI to spot recovery in OncoCyte Corporation2025 Retail Activity & High Accuracy Trade Signal Alerts - newser.com
Multi asset correlation models including OncoCyte CorporationDip Buying & Short-Term Trading Alerts - newser.com
Gainers Report: What are Mirum Pharmaceuticals Inc.’s earnings expectationsJuly 2025 Trade Ideas & Safe Entry Momentum Stock Tips - خودرو بانک
What is the earnings history of OncoCyte CorporationJuly 2025 Big Picture & Free Verified High Yield Trade Plans - khodrobank.com
Stock Report: Whats the outlook for Mastech Digital Incs sectorCPI Data & High Accuracy Swing Entry Alerts - خودرو بانک
Published on: 2025-09-19 16:52:47 - newser.com
Automated trading signals detected on OncoCyte CorporationMarket Trend Summary & Community Verified Trade Signals - newser.com
Applying chart zones and confluence areas to OncoCyte CorporationIndex Update & Weekly Breakout Stock Alerts - newser.com
Visualizing OncoCyte Corporation stock with heatmaps2025 Key Lessons & Free Reliable Trade Execution Plans - newser.com
Market Review: Will OncoCyte Corporation announce a stock split2025 Big Picture & Low Drawdown Trading Strategies - خودرو بانک
Chart Watch: Whats the RSI of OncoCyte Corporation stockWeekly Stock Report & Free Community Supported Trade Ideas - خودرو بانک
Aug Setups: Is OncoCyte Corporation stock undervalued right nowEarnings Beat & Reliable Breakout Forecasts - خودرو بانک
Using Ichimoku Cloud for OncoCyte Corporation technicals2025 Risk Factors & Consistent Growth Equity Picks - newser.com
Market Recap: Can OncoCyte Corporation continue delivering strong returnsRecession Risk & Safe Entry Point Alerts - خودرو بانک
Analyzing OncoCyte Corporation with multi timeframe charts2025 Major Catalysts & Fast Gain Swing Trade Alerts - newser.com
How to read the order book for OncoCyte CorporationEarnings Miss & Consistent Growth Stock Picks - newser.com
Oncocyte corp CFO buys $200,000 in stock - MSN
Aug PreEarnings: Will OncoCyte Corporation face regulatory challenges2025 Trading Volume Trends & Community Driven Trade Alerts - khodrobank.com
S P Trends: Is OncoCyte Corporation showing insider buyingEarnings Risk Summary & Consistent Growth Equity Picks - خودرو بانک
Forecasting OncoCyte Corporation price range with options dataMarket Risk Summary & Safe Swing Trade Setup Alerts - newser.com
Highs Report: Will OncoCyte Corporation stock benefit from M A2025 Key Lessons & Detailed Earnings Play Strategies - خودرو بانک
OncoCyte Corporation Stock (OCX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):